Rhode Island Code § 5-37-18.1

Physicians required to authorize product selection
Open in Lexace · Ask the AI about this section
Every licensed Rhode Island physician, when prescribing any drug by brand name, shall in each prescription, oral, written, or electronic, authorize a less expensive generic-equivalent drug product by signing the prescription. If, in the professional judgment of the prescribing physician, the brand name is medically necessary, the physician shall indicate “brand name necessary” on the prescription form. Pursuant to § 42-127.1-7 and chapter 19.1 of this title, an electronic signature shall satisfy this requirement.

‹ Prev All Rhode Island sections Next ›


Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Statute text is provided for general information and may not reflect the most recent amendments; verify against the official state code.